Brighter’s nomination committee for the Annual General Meeting 2019.

In accordance with the guidelines established at the AGM 2018, the nomination committee for Brighter’s AGM 2019 has now been appointed.

The committee consists of Barbro Fridén, acting chairperson of Brighter, Peter Näslund MD DLA Piper as Chairman of the Committee, as well as two representatives of the company's largest shareholders.

The nomination committee shall, before the annual general meeting 2019, prepare proposals for the election of chairman and other members of the board of directors, the election of chairman of the annual meeting, election of auditors, the determination of fees and matters pertaining thereto.

Shareholders who wish to submit proposals to the nomination committee for the annual general meeting on May 9th, 2019 can do so by email to boardnomination2019@brighter.se. Proposals should be submitted to the nomination committee before January 31, 2019.

For further information, please contact:

Truls Sjöstedt, CEO 
Phone: +46 709 73 46 00      
Email:  truls.sjostedt@brighter.se

Henrik Norström, COO   
Phone: +46 733 40 30 45      
Email: henrik.norstrom@brighter.se

About Brighter
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop® - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.